Age > 70 y | 176 | 2.24 | 0.99–5.08 | 0.054 | 1.29 | 0.45–3.69 | 0.632 | 5.42 | 1.58–18.62 | 0.007 |
T stage | 176 | | | <0.001 | | | 0.061 | | | 0.014 |
1 vs. 4 | | 0.09 | 0.01–0.65 | | 0 | Not applicable, no events | | 0.21 | 0.03–1.76 | |
2/3 vs. 4 | | 0.32 | 0.17–0.62 | | 0.42 | 0.21–0.86 | | 0.16 | 0.05–0.56 | |
Primary tumor SUV | 176 | 1.06 | 1.01–1.12 | 0.029 | 1.03 | 0.97−1.09 | 0.406 | 1.06 | 0.96–1.17 | 0.263 |
Primary tumor MTV* | 176 | 1.77 | 1.31–2.40 | <.001 | 1.89 | 1.35–2.65 | <.001 | 2.38 | 1.30–4.36 | 0.005 |
Primary tumor TLG* | 176 | 1.66 | 1.29–2.14 | <.001 | 1.56 | 1.20–2.04 | <.001 | 1.90 | 1.17–3.11 | 0.010 |
SUVmax in nodes | 176 | 1.06 | 1.00–1.11 | 0.033 | 1.08 | 1.02–1.13 | 0.004 | — | | — |
Maximum MTV in nodes* | 176 | 1.05 | 0.86–1.28 | 0.641 | 1.21 | 0.96−1.54 | 0.113 | — | | — |
Maximum TLG in nodes* | 176 | 1.11 | 0.94–1.32 | 0.217 | 1.25 | 1.03–1.52 | 0.025 | — | | — |
Level of spread in lymph nodes† | 176 | 2.21 | 1.16–4.19 | 0.015 | 2.47 | 1.21–5.05 | 0.013 | — | | — |
Smoking status | 176 | | | 0.2053 | | | 0.3102 | | | 0.9747 |
Former vs. never | | 0.94 | 0.43–2.06 | | 1.59 | 0.63–4.04 | | 1.15 | 0.29–4.62 | |
Current vs. never | | 1.78 | 0.77–4.13 | | 2.24 | 0.80–6.29 | | 1.02 | 0.17–6.11 | |